These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 12875974

  • 1. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
    Grzmil M, Thelen P, Hemmerlein B, Schweyer S, Voigt S, Mury D, Burfeind P.
    Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
    [Abstract] [Full Text] [Related]

  • 2. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
    Grzmil M, Voigt S, Thelen P, Hemmerlein B, Helmke K, Burfeind P.
    Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
    [Abstract] [Full Text] [Related]

  • 3. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P.
    J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
    [Abstract] [Full Text] [Related]

  • 4. Expression and functional analysis of Bax inhibitor-1 in human breast cancer cells.
    Grzmil M, Kaulfuss S, Thelen P, Hemmerlein B, Schweyer S, Obenauer S, Kang TW, Burfeind P.
    J Pathol; 2006 Feb; 208(3):340-9. PubMed ID: 16353131
    [Abstract] [Full Text] [Related]

  • 5. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K, Uemura H, Ishiguro H, Kubota Y.
    Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
    [Abstract] [Full Text] [Related]

  • 6. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T, Müller-Huesmann H, Riedel M, Kehlen A, Bialek J, Radestock Y, Holzhausen HJ, Steger K, Ludwig M, Weidner W, Hoang-Vu C, Hombach-Klonisch S.
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [Abstract] [Full Text] [Related]

  • 7. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C, Green JE.
    Cancer Res; 2002 Sep 15; 62(18):5325-35. PubMed ID: 12235003
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity.
    Gao AC, Lou W, Isaacs JT.
    Cancer Res; 1998 Apr 01; 58(7):1391-4. PubMed ID: 9537237
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer.
    Sidiropoulos M, Chang A, Jung K, Diamandis EP.
    Br J Cancer; 2001 Aug 03; 85(3):393-7. PubMed ID: 11487271
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.